Sphingolipid S1P: Potential new target for schizophrenia treatment
Sphingolipid S1P is reduced in brain white matter of people with schizophrenia, making S1P receptors a good target for new treatments.
Apr 29
Sphingolipid S1P is reduced in brain white matter of people with schizophrenia, making S1P receptors a good target for new treatments.
Apr 27
Staining that lights up whole organs and bodies
Scientists have developed a staining procedure that makes see-through tissue, organs, and bodies useful.
Jan 24
Astrocytes powered by norepinephrine during fear-memory formation
Norepinephrine released in the locus coeruleus during fear learning is accompanied by increased calcium and cAMP levels in nearby astrocytes.
Dec 19
Brain wave synchrony can predict memory age
The degree of neuronal synchrony between the anterior cingulate cortex and the hippocampus during recall is an indication of memory age (in mice).
Oct 29
Schizophrenia biomarker (hydrogen sulfide) in human hair
Not only is hydrogen sulfide a good biomarker for schizophrenia, it’s also the culprit and a new starting point for drug discovery.
Jun 27
Boosting betaine may be a treatment for schizophrenia
Supplementing model mice with glycine betaine (trimethylglycine), a compound originally derived from beets, can alleviate symptoms of schizophrenia.
RIKEN at a Glance
30-day trend
- January 23, 2025
Bye-bye microplastics: new plastic is fully ocean-degradable - November 26, 2020
Bacterial drug resistance studied by robotic E. coli evolution - May 22, 2025
Strong emotions plus non-REM sleep equals longer-lasting perceptual memories - April 5, 2022
Chaos theory provides hints for controlling the weather - August 20, 2024
Predictive grid cells help self navigation in the brain
Topics
